Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Maeda

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Scientific Reports|January 8, 2022
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
NPJ Biofilms and Microbiomes|December 31, 2019
Comparison of Japanese and Indian intestinal microbiota shows diet-dependent interaction between bacteria and fungiSiddhika Pareek, Takashi Kurakawa, Bhabatosh Das, et al.
The Lancet Regional Health. Western Pacific|December 26, 2022
Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in JapanYuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, et al.
Modern Rheumatology|August 13, 2022
Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Joint Bone Spine|May 27, 2026
Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: the ANSWER cohort studyYuki Etani, Yasutaka Okita, Yuichi Maeda, et al.
Rheumatology (Oxford, England)|October 30, 2024
Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritisNozomi Nishimura, Akira Onishi, Wataru Yamamoto, et al.
International Immunology|September 1, 2020
Increased levels of plasma nucleotides in patients with rheumatoid arthritisToshihiro Kishikawa, Yuichi Maeda, Takuro Nii, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2012
Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestineTakashi Kusu, Hisako Kayama, Makoto Kinoshita, et al.
Rheumatology (Oxford, England)|February 6, 2024
Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort studySadao Jinno, Akira Onishi, Shuhei Hattori, et al.
Annals of the Rheumatic Diseases|December 9, 2021
Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune diseaseYoshihiko Tomofuji, Toshihiro Kishikawa, Yuichi Maeda, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Scientific Reports|January 8, 2022
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
NPJ Biofilms and Microbiomes|December 31, 2019
Comparison of Japanese and Indian intestinal microbiota shows diet-dependent interaction between bacteria and fungiSiddhika Pareek, Takashi Kurakawa, Bhabatosh Das, et al.
The Lancet Regional Health. Western Pacific|December 26, 2022
Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in JapanYuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, et al.
Modern Rheumatology|August 13, 2022
Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Joint Bone Spine|May 27, 2026
Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: the ANSWER cohort studyYuki Etani, Yasutaka Okita, Yuichi Maeda, et al.
Rheumatology (Oxford, England)|October 30, 2024
Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritisNozomi Nishimura, Akira Onishi, Wataru Yamamoto, et al.
International Immunology|September 1, 2020
Increased levels of plasma nucleotides in patients with rheumatoid arthritisToshihiro Kishikawa, Yuichi Maeda, Takuro Nii, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2012
Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestineTakashi Kusu, Hisako Kayama, Makoto Kinoshita, et al.
Rheumatology (Oxford, England)|February 6, 2024
Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort studySadao Jinno, Akira Onishi, Shuhei Hattori, et al.
Annals of the Rheumatic Diseases|December 9, 2021
Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune diseaseYoshihiko Tomofuji, Toshihiro Kishikawa, Yuichi Maeda, et al.
Pageof 8